Timothy Keutzer

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Timothy Keutzer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Keutzer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Chief Operating Officer Common Stock 761,158 $1,704,993 $2.24 04 Feb 2026 Direct
Spero Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 137,000 02 Feb 2026 Direct

Insider Reports Filed by Timothy Keutzer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 02 Feb 2026 5 -$101,175 4 Chief Operating Officer 05 Feb 2026, 06:30
SPRO Spero Therapeutics, Inc. 28 Aug 2025 1 -$3,339 4 Chief Operating Officer 03 Sep 2025, 06:02
SPRO Spero Therapeutics, Inc. 03 Feb 2025 4 -$44,099 4 Chief Operating Officer 05 Feb 2025, 21:04
SPRO Spero Therapeutics, Inc. 27 Aug 2024 1 -$2,988 4 Chief Operating Officer 29 Aug 2024, 18:42
SPRO Spero Therapeutics, Inc. 01 Feb 2024 2 -$42,121 4 Chief Operating Officer 05 Feb 2024, 20:53
SPRO Spero Therapeutics, Inc. 28 Aug 2023 1 -$2,336 4 Chief Development Officer 30 Aug 2023, 17:23
SPRO Spero Therapeutics, Inc. 01 Feb 2023 2 -$6,313 4 Chief Operating Officer 03 Feb 2023, 18:43
SPRO Spero Therapeutics, Inc. 01 Feb 2022 2 $0 4 Chief Development Officer 03 Feb 2022, 15:18
SPRO Spero Therapeutics, Inc. 26 Aug 2021 1 $0 4 Chief Development Officer 30 Aug 2021, 16:15